{"id":"https://openalex.org/W2011155893","doi":"https://doi.org/10.1016/j.colsurfb.2011.07.060","title":"Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir","display_name":"Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir","publication_year":2011,"publication_date":"2011-08-08","ids":{"openalex":"https://openalex.org/W2011155893","doi":"https://doi.org/10.1016/j.colsurfb.2011.07.060","mag":"2011155893","pmid":"https://pubmed.ncbi.nlm.nih.gov/21865017"},"language":"en","primary_location":{"id":"doi:10.1016/j.colsurfb.2011.07.060","doi":"https://doi.org/10.1016/j.colsurfb.2011.07.060","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.colsurfb.2011.07.060","pdf_url":null,"source":{"id":"https://openalex.org/S22793308","display_name":"Colloids and Surfaces B Biointerfaces","issn_l":"0927-7765","issn":["0927-7765","1873-4367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Colloids and Surfaces B: Biointerfaces","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2011155893"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063177635","display_name":"Yung\u2010Chih Kuo","orcid":"https://orcid.org/0000-0002-5837-8546","observed_orcids":["https://orcid.org/0000-0002-5837-8546"]},"institutions":[{"id":"https://openalex.org/I148099254","display_name":"National Chung Cheng University","ror":"https://ror.org/0028v3876","country_code":"TW","type":"education","lineage":["https://openalex.org/I148099254"]}],"countries":["TW"],"is_corresponding":true,"raw_author_name":"Yung-Chih Kuo","raw_affiliation_strings":["Department of Chemical Engineering, National Chung Cheng University, Chia-Yi 62102, Taiwan, ROC. chmyck@ccu.edu.tw","Department of Chemical Engineering, National Chung Cheng University, Chia-Yi 62102, Taiwan, ROC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Engineering, National Chung Cheng University, Chia-Yi 62102, Taiwan, ROC. chmyck@ccu.edu.tw","institution_ids":["https://openalex.org/I148099254"]},{"raw_affiliation_string":"Department of Chemical Engineering, National Chung Cheng University, Chia-Yi 62102, Taiwan, ROC","institution_ids":["https://openalex.org/I148099254"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103448090","display_name":"Chiu\u2010Yen Chung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I148099254","display_name":"National Chung Cheng University","ror":"https://ror.org/0028v3876","country_code":"TW","type":"education","lineage":["https://openalex.org/I148099254"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Chiu-Yen Chung","raw_affiliation_strings":["Department of Chemical Engineering, National Chung Cheng University, Chia-Yi 62102, Taiwan, ROC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Engineering, National Chung Cheng University, Chia-Yi 62102, Taiwan, ROC","institution_ids":["https://openalex.org/I148099254"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5063177635"],"corresponding_institution_ids":["https://openalex.org/I148099254"],"apc_list":{"value":3790,"currency":"USD","value_usd":3790},"apc_paid":null,"fwci":1.8873,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.82863895,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"88","issue":"2","first_page":"682","last_page":"690"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.4731000065803528,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.4731000065803528,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.23569999635219574,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.2159000039100647,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/solid-lipid-nanoparticles","display_name":"solid lipid nanoparticles","score":1.0},{"id":"https://openalex.org/keywords/compritol-888-ato","display_name":"Compritol 888 ATO","score":0.9089999794960022},{"id":"https://openalex.org/keywords/tripalmitin","display_name":"tripalmitin","score":1.0},{"id":"https://openalex.org/keywords/cocoa-butter","display_name":"cocoa butter","score":0.9929999709129333},{"id":"https://openalex.org/keywords/stavudine","display_name":"stavudine","score":0.9629999995231628},{"id":"https://openalex.org/keywords/delavirdine","display_name":"delavirdine","score":0.996999979019165},{"id":"https://openalex.org/keywords/saquinavir","display_name":"saquinavir","score":1.0},{"id":"https://openalex.org/keywords/antiretroviral-drugs","display_name":"antiretroviral drugs","score":0.9010000228881836},{"id":"https://openalex.org/keywords/drug-encapsulation","display_name":"drug encapsulation","score":0.7749999761581421},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.8349999785423279},{"id":"https://openalex.org/keywords/encapsulation-efficiency","display_name":"encapsulation efficiency","score":0.9100000262260437},{"id":"https://openalex.org/keywords/particle-size","display_name":"particle size","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C199529486","wikidata":"https://www.wikidata.org/wiki/Q7557912","display_name":"Solid lipid nanoparticle","level":3,"score":0.9437812566757202},{"id":"https://openalex.org/C2776937687","wikidata":"https://www.wikidata.org/wiki/Q422654","display_name":"Saquinavir","level":5,"score":0.8554763793945312},{"id":"https://openalex.org/C2780859203","wikidata":"https://www.wikidata.org/wiki/Q7843226","display_name":"Tripalmitin","level":2,"score":0.7778886556625366},{"id":"https://openalex.org/C2779889181","wikidata":"https://www.wikidata.org/wiki/Q423984","display_name":"Stavudine","level":5,"score":0.7523487210273743},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5538336038589478},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5080413818359375},{"id":"https://openalex.org/C2777210460","wikidata":"https://www.wikidata.org/wiki/Q425490","display_name":"Indinavir","level":5,"score":0.4911034107208252},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3830283284187317},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.35703229904174805},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.18917256593704224},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11063385009765625},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0873079001903534},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.06714832782745361},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.0},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002099","descriptor_name":"Cacao","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018119","descriptor_name":"Stavudine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018119","descriptor_name":"Stavudine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D019258","descriptor_name":"Saquinavir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019258","descriptor_name":"Saquinavir","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D020008","descriptor_name":"Delavirdine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020008","descriptor_name":"Delavirdine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.colsurfb.2011.07.060","doi":"https://doi.org/10.1016/j.colsurfb.2011.07.060","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.colsurfb.2011.07.060","pdf_url":null,"source":{"id":"https://openalex.org/S22793308","display_name":"Colloids and Surfaces B Biointerfaces","issn_l":"0927-7765","issn":["0927-7765","1873-4367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Colloids and Surfaces B: Biointerfaces","raw_type":"journal-article"},{"id":"pmid:21865017","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21865017","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Colloids and surfaces. B, Biointerfaces","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321040","display_name":"National Science Council","ror":"https://ror.org/02kv4zf79"},{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W137791175","https://openalex.org/W179797399","https://openalex.org/W1579046626","https://openalex.org/W1967221196","https://openalex.org/W1997128098","https://openalex.org/W1997988583","https://openalex.org/W2000269813","https://openalex.org/W2001590303","https://openalex.org/W2003631032","https://openalex.org/W2009424304","https://openalex.org/W2020882358","https://openalex.org/W2031362742","https://openalex.org/W2044681516","https://openalex.org/W2054189154","https://openalex.org/W2056152001","https://openalex.org/W2060909088","https://openalex.org/W2062330335","https://openalex.org/W2065324366","https://openalex.org/W2065817859","https://openalex.org/W2076341348","https://openalex.org/W2080425462","https://openalex.org/W2085782819","https://openalex.org/W2086020611","https://openalex.org/W2087707746","https://openalex.org/W2090429604","https://openalex.org/W2092370160","https://openalex.org/W2093004080","https://openalex.org/W2100343850","https://openalex.org/W2102738613","https://openalex.org/W2142788272","https://openalex.org/W2163695841","https://openalex.org/W2339922662"],"related_works":["https://openalex.org/W4392930432","https://openalex.org/W2031362742","https://openalex.org/W7149634983","https://openalex.org/W2075015873","https://openalex.org/W2972755611","https://openalex.org/W2610189975","https://openalex.org/W2330882647","https://openalex.org/W2089854063","https://openalex.org/W2923432639","https://openalex.org/W2748433674"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}